These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23463969)

  • 21. Omega-3-carboxylic acid (Epanova) for hypertriglyceridemia.
    Zhao A; Lam S
    Cardiol Rev; 2015; 23(3):148-52. PubMed ID: 25580706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of eicosapentaenoic acid and docosahexaenoic acid on lipoproteins in hypertriglyceridemia.
    Patel AA; Budoff MJ
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):145-9. PubMed ID: 26825470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 carboxylic acids (Epanova): a review of its use in patients with severe hypertriglyceridemia.
    Blair HA; Dhillon S
    Am J Cardiovasc Drugs; 2014 Oct; 14(5):393-400. PubMed ID: 25234378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study.
    Tatsuno I; Saito Y; Kudou K; Ootake J
    J Clin Lipidol; 2013; 7(6):615-25. PubMed ID: 24314359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omacor effects on serum lipids and clinical outcome.
    Ito MK; Marrs J; Williams C
    Am J Cardiol; 2007 Jan; 99(1):145. PubMed ID: 17196478
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events.
    McCullough PA; Ahmed AB; Zughaib MT; Glanz ED; Di Loreto MJ
    Rev Cardiovasc Med; 2011; 12(4):173-85. PubMed ID: 22249508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bridging the gap in treatment options for patients with hypertriglyceridemia.
    Underberg JA; Hays R
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
    Benes LB; Bassi NS; Davidson MH
    Vasc Health Risk Manag; 2016; 12():481-490. PubMed ID: 28003756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective case series of the lipid effects of switching from omega-3 fatty acid ethyl esters to icosapent ethyl in hyperlipidemic patients.
    Castaldo RS
    Postgrad Med; 2014 May; 126(3):268-73. PubMed ID: 24977343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.
    Nordøy A
    Minerva Med; 2002 Oct; 93(5):357-63. PubMed ID: 12410168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease.
    Weisman D; Motro M; Schwammenthal E; Fisman EZ; Tenenbaum A; Tanne D; Adler Y
    Isr Med Assoc J; 2004 Apr; 6(4):227-32. PubMed ID: 15115262
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.
    Pirillo A; Catapano AL
    Drug Des Devel Ther; 2015; 9():2129-37. PubMed ID: 25914523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
    Skulas-Ray AC; West SG; Davidson MH; Kris-Etherton PM
    Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel developments in omega-3 fatty acid-based strategies.
    Davidson MH; Kling D; Maki KC
    Curr Opin Lipidol; 2011 Dec; 22(6):437-44. PubMed ID: 21986642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-chain omega-3 fatty acids: highly concentrated only as ethyl ester].
    MMW Fortschr Med; 2005 Oct; 147(43):61. PubMed ID: 16302427
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea.
    Kim HS; Kim H; Jeong YJ; Yang SJ; Baik SJ; Lee H; Lee SH; Cho JH; Choi IY; Yim HW; Yoon KH
    J Clin Pharm Ther; 2016 Oct; 41(5):508-14. PubMed ID: 27426000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study.
    De Luis DA; Conde R; Aller R; Izaola O; González Sagrado M; Perez Castrillón JL; Dueñas A; Romero E
    Eur Rev Med Pharmacol Sci; 2009; 13(1):51-5. PubMed ID: 19364085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides.
    Sadovsky R; Kris-Etherton P
    Postgrad Med; 2009 Jul; 121(4):145-53. PubMed ID: 19641280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hypertriglyceridemia with omega-3 fatty acids].
    Miyoshi T; Ito H
    Nihon Rinsho; 2013 Sep; 71(9):1650-4. PubMed ID: 24205729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia.
    McKeone BJ; Osmundsen K; Brauchi D; Pao Q; Payton-Ross C; Kilinç C; Kummerow FA; Pownall HJ
    J Lipid Res; 1997 Mar; 38(3):429-36. PubMed ID: 9101424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.